Feeding filaggrin: effects of L-histidine supplementation in atopic dermatitis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (AD), also known as eczema, is one of the most common chronic skin conditions worldwide, affecting up to 16% of children and 10% of adults. It is incurable and has significant psychosocial and economic impacts on the affected individuals. AD etiology has been linked to deficiencies in the skin barrier protein, filaggrin. In mammalian skin, l-histidine is rapidly incorporated into filaggrin. Subsequent filaggrin proteolysis releases l-histidine as an important natural moisturizing factor (NMF). In vitro studies were conducted to investigate the influence of l-histidine on filaggrin processing and barrier function in human skin-equivalent models. Our further aim was to examine the effects of daily oral l-histidine supplementation on disease severity in adult AD patients. We conducted a randomized, double-blind, placebo-controlled, crossover, nutritional supplementation pilot study to explore the effects of oral l-histidine in adult AD patients (n=24). In vitro studies demonstrated that l-histidine significantly increased both filaggrin formation and skin barrier function ( P <0.01, respectively). Data from the clinical study indicated that once daily oral l-histidine significantly reduced ( P <0.003) AD disease severity by 34% (physician assessment using the SCORingAD tool) and 39% (patient self-assessment using the Patient Oriented Eczema Measure tool) after 4 weeks of treatment. No improvement was noted with the placebo ( P >0.32). The clinical effect of oral l-histidine in AD was similar to that of mid-potency topical corticosteroids and combined with its safety profile suggests that it may be a safe, nonsteroidal approach suitable for long-term use in skin conditions that are associated with filaggrin deficits such as AD. Keywords: atopic dermatitis, eczema, filaggrin, l-histidine, amino acid, skin barrier, nutritional supplement
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
WILLIAMS, H. C., JBURNEY, P. G., HAY, R. J., ARCHER, C. B., SHIPLEY, M. J., AHUNTER, J. J., BINGHAM, E. A., FINLAY, A. Y., PEMBROKE, A. C., CGRAHAM-BROWN, R. A., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08530.x · Cited by 1,271
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217 · cited 1×
“7,8 Profilaggrin, originally called “histidine-rich protein” because of its very high ( ~ 10”
One remarkable molecule: filaggrin
Brown, S. J., & Irwin McLean, W. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.393 · Cited by 527 · cited 1×
“It accumulates in keratohyalin granules before dephosphorylation and processing, via lower weight intermediates, to ~37 kDa filaggrin monomers.(10,11) Filaggrin aggregates cytokeratins 1 and 10 and other intermediate filaments in the granular layer of keratinocytes, “collapsing” them as part of the epidermal terminal…”
Self-citationWhat are the best outcome measurements for atopic eczema? A systematic review
Schmitt, J., Langan, S., & Williams, H. C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.011 · Cited by 388 · cited 4×
“Immortalized human HaCaT keratinocytes 29 of passages 35–41 (gift from Dr J. Wood, University of Dundee; origin – German Cancer Research Center (DKFZ), Heidelberg, Germany) were seeded in six-well cell culture plates (Corning Incorporated, Corning, NY, USA) in D-MEM/F-12 medium with GlutaMAX…”
InfluentialKezic, S., O’Regan, G. M., Yau, N., Sandilands, A., Chen, H., Campbell, L. E., Kroboth, K., Watson, R., Rowland, M., Irwin McLean, W. H., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02540.x · Cited by 295
Cited by
Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement
Holeček, M. (2020) · Nutrients · doi:10.3390/nu12030848 · Cited by 485
The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair
Rajkumar, J., Chandan, N., Lio, P., & Shi, V. (2023) · Skin Pharmacology and Physiology · doi:10.1159/000534136 · Cited by 193
“Oral L -histidine supplementation signi fi cantly reduced SCORAD by 34% and 32% at 4-and 8-weeks treatment duration compared to placebo in a pilot study of adults with moderate AD [53].”
BackgroundThe multiple roles of urocanic acid in health and disease
Hart, P. H., & Norval, M. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.07.017 · Cited by 68
Kim, Y., Kim, E., & Kim, Y. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.060 · Cited by 35
Metadata
- Authors
- Tan, S. P., Brown, S. B., Griffiths, C., Weller, R., & Gibbs, N. K.
- Venue
- Clinical, Cosmetic and Investigational Dermatology
- Publisher
- Informa UK Limited
- Published
- 2017-10
- Volume
- Volume 10
- Pages
- 403-411
- ISSN
- 1178-7015 (ISSN-L)
- OpenAlex
- W2761406325
- Cited by
- 55
- References
- 8
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Feeding filaggrin: effects of L-histidine supplementation in atopic dermatitis. https://app.cochat.ai/papers/10.2147/ccid.s146760
- The paper
- Tan, S. P., Brown, S. B., Griffiths, C., Weller, R., & Gibbs, N. K. (2017). Feeding filaggrin: effects of L-histidine supplementation in atopic dermatitis. Clinical, Cosmetic and Investigational Dermatology. https://doi.org/10.2147/ccid.s146760
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.